Compounds > lovastatin
Page last updated: 2024-08-23

lovastatin and Local Neoplasm Recurrence

lovastatin has been researched along with Local Neoplasm Recurrence in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castro-Vázquez, SS; De La Fuente-Granada, M; González-Arenas, A; Guerrero-Rodríguez, SL; Mondragon-Peralta, A; Pérez-Tapia, SM; Vásquez-Bochm, LX; Velasco-Velázquez, MA; Velázquez-Paniagua, M1
Adamczyk-Cioch, M; Dmoszynska, A; Grzasko, N; Helbig, G; Hus, M; Jawniak, D; Kozinska, J; Legiec, W; Morawska, M; Pluta, A; Szostek, M; Waciński, P; Woszczyk, D1
Chen, E; Chin, S; Dimitroulakos, J; Irish, J; Kamel-Reid, S; Knox, JJ; LaFramboise, S; Moore, MJ; Oza, AM; Siu, LL1

Trials

2 trial(s) available for lovastatin and Local Neoplasm Recurrence

ArticleYear
Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma.
    Annals of hematology, 2011, Volume: 90, Issue:10

    Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Resistance, Neoplasm; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunomodulation; Immunosuppressive Agents; Lovastatin; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Salvage Therapy; Stem Cell Transplantation; Survival Analysis; Thalidomide; Transplantation, Autologous

2011
A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix.
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:4

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Uterine Cervical Neoplasms

2005

Other Studies

1 other study(ies) available for lovastatin and Local Neoplasm Recurrence

ArticleYear
Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug.
    Pharmacological reports : PR, 2019, Volume: 71, Issue:3

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Drug Delivery Systems; Female; Humans; Lovastatin; Mice; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Promoter Regions, Genetic; SOXB1 Transcription Factors; Transcriptional Activation; Transcriptome

2019